Sanofi launches patent case over Alphapharm injector pen

Healthcare 2018-08-21 11:00 pm By Miklos Bolza | Sydney

Please login to bookmark

Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking “urgent interlocutory relief” to prevent a generic injector pen from being listed on the market.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au